← ANALYST RATINGS · TIPRANKS
Integer Holdings (ITGR): analyst forecast and price target
Analyst consensus
Hold0 Buy7 Hold0 Sell
Ratings of 7 analysts in the last 3 months12-month forecast
Based on 7 price targets given in the last 3 months, the average target is $127, the highest $127, the lowest $127. The average is +0.2% from the last price of $127.
Analyst ratings 11
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $142 → $141−0.7% | Buy | +11.3% | Reiterated | 30.09.26on TipRanks 15:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $142 → $140−1.4% | Buy | +10.5% | Reiterated | 30.09.26on TipRanks 15:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $138 | Hold | +8.9% | Reiterated | 30.09.26on TipRanks 15:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $134 → $133−0.7% | Hold | +5.0% | Reiterated | 30.09.26on TipRanks 15:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $145 → $141−2.8% | Buy | +11.3% | Reiterated | 30.09.26on TipRanks 15:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $137 | Hold | +8.1% | Reiterated | 30.09.26on TipRanks 15:05 | — | |
| Keith Hinton★★★★★★★★★★#7123 · hits 80% · avg +7.0% | Freedom Capital Markets | $112 → $127+13.4% | Hold | +0.2% | Downgrade | 04.08.26on TipRanks Sep 27 05:10 | −1.3%next day +0.2% · 5 days +0.1% | ↗ |
| Unknown Analyst | Wells Fargo | $84.00 → $127+51.2% | Hold | +0.2% | Reiterated | 04.08.26on TipRanks 07:55 | −1.3%next day +0.2% · 5 days +0.1% | ↗ |
| Suraj Kalia★★★★★★★★★★#1646 · hits 50% · avg +6.8% | Oppenheimer | — | Hold | — | Downgrade | 04.08.26on TipRanks Aug 3 16:40 | −1.3%next day +0.2% · 5 days +0.1% | ↗ |
| Richard Newitter★★★★★★★★★★#1772 · hits 48% · avg +6.6% | Truist Financial | $110 → $127+15.5% | Hold | +0.2% | Downgrade | 04.08.26on TipRanks Aug 3 11:20 | +1.2%next day −1.3% · 5 days −1.5% | ↗ |
| Andrew Cooper★★★★★★★★★★#11107 · hits 40% · avg −3.0% | Raymond James | — | Hold | — | Downgrade | 03.08.26on TipRanks 10:25 | +1.2%next day −1.3% · 5 days −1.5% | ↗ |
| Matthew O'Brien★★★★★★★★★★#12031 · hits 41% · avg −4.5% | Piper Sandler | $127 | Hold | +0.2% | Downgrade | 03.08.26on TipRanks 09:10 | +1.2%next day −1.3% · 5 days −1.5% | ↗ |
| Brett Fishbin★★★★★★★★★★#10514 · hits 45% · avg −3.0% | KeyBanc | — | Hold | — | Downgrade | 03.08.26on TipRanks 08:45 | +1.2%next day −1.3% · 5 days −1.5% | ↗ |
| Joanne Wuensch★★★★★★★★★★#3684 · hits 55% · avg +2.3% | Citi | $92.00 → $96.00+4.3% | Hold | −24.2% | Reiterated | 08.07.26on TipRanks 05:40 | −0.5%next day 0.0% · 5 days +3.6% | ↗ |
| Craig Bijou★★★★★★★★★★#7826 · hits 41% · avg +0.2% | Bank of America Securities | $91.00 → $98.00+7.7% | Hold | −22.7% | Reiterated | 30.04.26on TipRanks 15:35 | +4.8%next day −5.3% · 5 days −2.5% | ↗ |
| Robert Wasserman★★★★★★★★★★#2200 · hits 44% · avg +9.2% | Benchmark Co. | $95.00 | Buy | −25.0% | Upgrade | 20.02.26on TipRanks 07:10 | +1.5%next day +2.1% · 5 days +2.7% | ↗ |
| Steven Silver★★★★★★★★★★#2962 · hits 80% · avg +22.7% | Argus Research | — | Hold | — | Downgrade | 24.10.25on TipRanks 14:00 | −2.1%next day −4.9% · 5 days −12.1% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Integer Holdings
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $121 at a price of $126 (−4.4%); now: $127 at $127 (+0.2%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 3 | 5 | 2 | 2 | 0 |
| Hold | 5 | 4 | 3 | 8 | 8 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 22.10.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $1.68 (from $1.62 to $1.76). Last quarter: $1.60.
Sales
Next quarter’s sales estimate — $457M (from $450M to $464M). Last quarter: $460M.
Best top-analyst consensus in the sector · Healthcare
About Integer Holdings
- CEO: Payman Khales
- Employees: 11,000
- 5830 Granite Parkway, Plano, TX, 75024, US
- www.integer.net
Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers
Data from the stock’s TipRanks forecast page, read 49 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗